Mijin Kim
-
- RNA Research and Splicing 4
- Natural product bioactivities and synthesis 3
- Genomics and Chromatin Dynamics 3
- Renal and related cancers 3
- Nephrology top 10%
- Pharmacology top 10%
- Pharmacological Effects of Natural Compounds 5
-
- Osteoarthritis Treatment and Mechanisms 4
-
- Tryptophan and brain disorders 3
-
- Bioactive Compounds and Antitumor Agents 2
- Co-authors
- Byoung‐Hyun MinByung Hyune ChoiM. Todd ValeriusAndrew P. McMahonRaphael KopanKameswaran SurendranAchim GosslerHui‐Teng Cheng
- Journals
- Journal of Biological Chemistry (1 paper)Development (3 papers)Scientific Reports (1 paper)
- Partner nations
- South KoreaUnited StatesSwitzerland
In The Last Decade
Mijin Kim
41 papers receiving 914 citations
Peers
Comparison fields: 5 of 112
- Molecular Biology 624
- Cancer Research 126
- Nephrology 47
- Genetics 63
- Pharmacology 44
Countries citing papers authored by Mijin Kim
This map shows the geographic impact of Mijin Kim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mijin Kim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mijin Kim more than expected).
Fields of papers citing papers by Mijin Kim
This network shows the impact of papers produced by Mijin Kim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mijin Kim. The network helps show where Mijin Kim may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mijin Kim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 12 | |
| 3 | 2023 | 1 | |
| 4 | 2023 | 4 | |
| 5 | 2022 | 6 | |
| 6 | 2022 | 3 | |
| 7 | 2021 | 11 | |
| 8 | 2019 | 19 | |
| 9 | 2018 | 130 | |
| 10 | 2015 | 8 | |
| 11 | 2014 | 42 | |
| 12 | 2009 | 3 | |
| 13 | 2009 | 12 | |
| 14 | 2008 | 3 | |
| 15 | 2007 | 262 | |
| 16 | Synovial Sarcoma with Massive Myxoid Feature - A Case Report - | 2005 | 1 |
| 17 | 2005 | 4 | |
| 18 | 2005 | 42 | |
| 19 | Effect of Angiotensin II Receptor Blockade on VEGF Expression in Diabetic Nephropathy. | 2003 | 1 |
| 20 | 1999 | 10 |
About Mijin Kim
Mijin Kim is a scholar working on Biological Psychiatry, Pharmacology and Toxicology, having authored 42 papers that have together received 937 indexed citations. Recurring topics across this work include Pharmacological Effects of Natural Compounds (5 papers), Osteoarthritis Treatment and Mechanisms (4 papers), RNA Research and Splicing (4 papers), Natural product bioactivities and synthesis (3 papers), Genomics and Chromatin Dynamics (3 papers), Renal and related cancers (3 papers), Tryptophan and brain disorders (3 papers) and Bioactive Compounds and Antitumor Agents (2 papers). The work is most often cited by research in Molecular Biology (624 citations), Cancer Research (126 citations) and Nephrology (47 citations). Mijin Kim has collaborated with scholars based in South Korea, United States and Switzerland. Frequent co-authors include Byoung‐Hyun Min, Byung Hyune Choi, M. Todd Valerius, Andrew P. McMahon, Raphael Kopan, Kameswaran Surendran, Achim Gossler, Hui‐Teng Cheng, Karin Schuster-Gossler and Do Young Park. Their work appears in journals such as Journal of Biological Chemistry, Development and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.